OBETAT is dedicated for development and commercialization of breakthrough therapy in meeting unmet needs of treating Severe Obesity and Prader Willi Syndrome (orphan disease) in USA and global market.
Obetat has three peptides compounds (with amnio acids 26, 38 71) for Severe Obesity, Prade Willin Syndrome, Diabetes, and Fatty Liver Disease.
Like this:
Like Loading...
Obetat Biopharma 
